Leen Jille — hera - right to health and development

Leen Jille, MPH, Public Health expert

Leen is a public health specialist with a focus on health systems, policy, global health and procurement and supply management, with more than 15 years of relevant work experience.

He has a broad range of expertise in strategic analysis, results and performance assessments, and different evaluation methods.
Leen worked in more than 25 countries in the Global South and lived in Nicaragua, the Democratic Republic of Congo, Ukraine and Mozambique.
On behalf of hera, he has led several projects for bilateral and multilateral agencies, Global Health Initiatives and NGOs.
Leen joined hera as a partner in 2014 as a Pharmaceutical procurement and supply chain management expert. He has been a Board member since 2018 and Board Chair from 2019 until early 2021 when he was elected hera’s Chief Executive Officer (CEO).
He is deeply embedded in hera’s culture, and as CEO, he is responsible for planning, implementing and integrating hera’s strategic direction.
Leen holds a master’s degree in public health (orientation Health Systems Management and Policy) from the Antwerp Institute of Tropical Medicine and a Certificate in Global Health Diplomacy from the State University of New York.
He is Dutch and fluent in English, French, Spanish and Portuguese.

In 2023 hera was selected to undertake a critical review of the "Partnering for Transformational Change: Strengthening Liberia’s Surgical Health System" project. This initiative, implemented by Mercy Ships and funded by Norad, was established against the backdrop of Liberia's challenging healthcare environment, particularly in its surgical health system.

Advancing Equitable COVID-19 Vaccination in Humanitarian Crisis

The World Health Organization (WHO), taking the lead in responding to this pressing issue, selected hera to conduct a study on the complexities of COVID-19 vaccine deployment and administration in humanitarian settings, with a specific focus on populations of concern (PoC). The study was initiated in March 2022 and concluded in March 2023, and encompassed case studies in multiple countries deeply affected by humanitarian crises: Cox's Bazar (Bangladesh), Colombia, the Democratic Republic of the Congo (DRC), Iraq, South Sudan, and Syria.

Unpacking from the Health Systems Research Symposium (HSR 2022) – Bogotá, Colombia

At the end of October this year, hera’s Director Marieke Devillé, CEO Leen Jille and Project Officer Alice Peschiutta made the trip to attend HSR2022 in Bogota, Colombia. By all accounts, it was an engaging experience and a positive immersion in health systems research.

Norad Country Evaluation Brief: Democratic Republic of the Congo

The Norwegian agency for development cooperation (Norad) recently published a Country Evaluation Brief on the Democratic Republic of the Congo (DRC) prepared by a hera team of researchers.’

Gavi, the Vaccine Alliance’s (Gavi’s) Fragility, Emergencies and Refugees (FER) policy

Gavi, the Vaccine Alliance’s (Gavi’s) Fragility, Emergencies and Refugees (FER) policy has been in effect since June 2017.

Evaluation of the Médecins Sans Frontières (MSF) Operational Centre Brussels (OCB) Supply

hera to support Health Systems Global in developing a new 5-year strategic plan

A hera team, led by CEO Leen Jille and Associate Partner Giorgia Lattanzi, has been selected to support Health Systems Global (HSG) in developing its next 5-Year Strategic plan covering 2021-2026. The aim is to develop a strategic framework that continues to position HSG at “the forefront of health systems policy and research within the changing landscape of global health.”

Changes at hera - A message from Leo Devillé

Procurement for health in Namibia

Mozambique - MTR cooperation Flanders Mozambique - Flanders BuZa

hera's MTR evaluated implementation progress, identified challenges, and provided recommendations for improvement. The findings helped shape the subsequent CSP phase, emphasizing innovation and addressing key healthcare issues.

External Evaluation of the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) 2013-2017

hera was selected to conduct the fourth external evaluation of the HRP covering the period from January 2013 to December 2017.

SADC Feasibility Study on Regional Manufacturing of Medicines and Health Commodities

Assess the feasibility of the local production of essential medicines especially those related to the three communicable diseases, namely HIV and AIDS, TB and Malaria as well as the production of health commodities for the three diseases.

Leen Jille, MPH, Public Health expert

Related Stories